Looking to boost your energy, support DNA repair, enhance skin health, reduce inflammation, and sleep better? NAD+ supplementation might be just what you need! Nicotinamide adenine dinucleotide (NAD+) is a powerhouse coenzyme that plays a critical role in cellular energy production. Unfortunately, as we age, our NAD+ levels naturally decline—taking our youthful energy with it. …
Looking to boost your energy, support DNA repair, enhance skin health, reduce inflammation, and sleep better? NAD+ supplementation might be just what you need!
Nicotinamide adenine dinucleotide (NAD+) is a powerhouse coenzyme that plays a critical role in cellular energy production. Unfortunately, as we age, our NAD+ levels naturally decline—taking our youthful energy with it. First discovered over 100 years ago as part of the electron transport chain in mitochondria, NAD+ has since been shown to improve energy efficiency and treat conditions like actinic keratosis, addiction withdrawals, and even the muscle symptoms of Parkinson’s disease.
Our bodies can make NAD+ using vitamin B3 derivatives like nicotinic acid (NA), nicotinamide mononucleotide (NMN), or nicotinamide riboside (NR). But oral supplements lose potency as they pass through the liver, making intramuscular (IM) or intravenous (IV) therapy the best options. At The Peak, we recommend NAD+ IM injections twice a week. Unlike IV infusions, which take hours, IM injections are a quick 10-minute visit—perfect for anyone with a busy schedule but looking for similar benefits after multiple sessions.
So, ready to recharge your cells and feel more like you again? NAD+ might be your secret weapon!
References:
Birkmayer JG, Vrecko C, Volc D, Birkmayer W. Nicotinamide adenine dinucleotide (NADH)–a new therapeutic approach to Parkinson’s disease. Comparison of oral and parenteral application. Acta Neurol Scand Suppl. 1993;146:32-5. PMID: 8101414.
Jacobson E.L., Kim H., Kim M., Williams J.D., Coyle D.L., Coyle W.R., Grove G., Rizer R.L., Stratton M.S., Jacobson M.K. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp. Dermatol. 2007;16:490–499. doi: 10.1111/j.1600-0625.2007.00553.x. [PubMed] [CrossRef] [Google Scholar]
Radenkovic D, Reason, Verdin E. Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals (Basel). 2020 Sep 15;13(9):247. doi: 10.3390/ph13090247. PMID: 32942582; PMCID: PMC7558103.
